Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 2,102,548 |
|
|||||
| News | - | ||||||
| Day High | 17.60 | Low High |
|||||
| Day Low | 15.42 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immunome Inc | IMNM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.18 | -6.87% | 16.00 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.26 | 15.42 | 17.60 | 15.48 | 17.18 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 20,599 | 2,102,548 | $ 16.16 | $ 33,973,812 | - | 4.44 - 30.958 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:44:44 | formt | 200 | $ 16.00 | USD |
Immunome Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 662.31M | 42.73M | - | 14.02M | -106.81M | -2.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immunome News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMNM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.55 | 21.72 | 15.42 | 18.12 | 738,482 | -4.55 | -22.14% |
| 1 Month | 25.30 | 26.70 | 15.42 | 21.22 | 687,504 | -9.30 | -36.76% |
| 3 Months | 16.48 | 30.958 | 15.42 | 22.56 | 769,050 | -0.48 | -2.91% |
| 6 Months | 8.59 | 30.958 | 6.93 | 19.49 | 484,129 | 7.41 | 86.26% |
| 1 Year | 5.33 | 30.958 | 4.44 | 16.71 | 315,876 | 10.67 | 200.19% |
| 3 Years | 24.21 | 32.4476 | 2.09 | 15.88 | 184,072 | -8.21 | -33.91% |
| 5 Years | 15.66 | 63.78 | 2.09 | 17.83 | 180,710 | 0.34 | 2.17% |
Immunome Description
| Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. |
